Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04376346 · ClinicalTrials.gov registry record · NA
Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES
A NA study of Alcohol Exposed Pregnancy, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 439
- Enrollment target
- 1
- Study location
NCT04376346: Completed NA study of Alcohol Exposed Pregnancy, sponsored by University of Colorado, Denver.
NCT04376346 is a NA study of Alcohol Exposed Pregnancy that has completed, run by University of Colorado, Denver. The registered enrollment target is 439 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04376346, a NA study of Alcohol Exposed Pregnancy, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 439 participants
- Enrollment target
- 1
- Study location
Study Summary
Fetal Alcohol Syndrome Disorders (FASD) result in lifelong disability and are a leading cause of preventable birth defects in the US. Urban American Indian and Alaska Native (AIAN) young women are at high risk for alcohol exposed pregnancies (AEPs) which can cause FASD. In this project, the inverstigators will test the effectiveness of a culturally adapted mobile health intervention to prevent AEP, using social media to recruit AIAN young women from urban centers across the nation.
Primary Outcome
Had at least one alcoholic drink in past 30 days (Y/N)
Conditions Studied
Interventions
- BEHAVIORAL Native WYSE CHOICES
Study Locations (1)
Colorado
- University of Colorado- Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 439 participants |
| Start Date | 2021-08-04 |
| Est. Completion | 2024-02-25 |
| Phase | NA |
What the finished NCT04376346 record still lists
NCT04376346 is an interventional study that assigns participants to a tested intervention. The registered 439 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Alcohol Exposed Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Native WYSE CHOICES is the first listed.
NCT04376346 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04376346 about?
NCT04376346 is a clinical study titled "Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES". Fetal Alcohol Syndrome Disorders (FASD) result in lifelong disability and are a leading cause of preventable birth defects in the US. Urban American Indian and Alaska Native (AIAN) young women are at high risk for alcohol exposed pregnancies (AEPs) which can cause FASD. In this project, the inversti...
What is the current status of trial NCT04376346?
This trial is currently completed. It is a NA study. The enrollment target is 439 participants. The study started on 2021-08-04. Estimated completion is 2024-02-25.
What conditions does trial NCT04376346 study?
This clinical trial studies the following conditions: Alcohol Exposed Pregnancy.
What interventions are being tested in trial NCT04376346?
The interventions under investigation include: Native WYSE CHOICES (BEHAVIORAL).
Who is sponsoring clinical trial NCT04376346?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04376346 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Exposed Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04376346's enrollment target sits among peer trials
439 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421663 · 439 participants · Phase 1
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
- NCT06235151 · 439 participants · Phase 3
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI